powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1003256553
Yazan Madanat
M.D
Hematology-Oncology
Dallas,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
82.9
Quality
70.2
Cost
72.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.33%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 458194
Home health agency
CCN 450044
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,272
Beneficiaries
—
Total drug cost
$4.8M
Distinct drugs
34
Brand share
24.8%
Top prescribed drugs
Acyclovir
270 claims
Allopurinol
131 claims
Ruxolitinib Phosphate
88 claims
Levofloxacin
83 claims
Ursodiol
65 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$14K
Payment records
17
By payment type
Consulting Fee
$11K
Honoraria
$3K
Travel and Lodging
$856
Food and Beverage
$482
Top paying entities
Consulting Fee
$11K
Honoraria
$3K
Travel and Lodging
$856
Food and Beverage
$482
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
237
Unique beneficiaries
—
Total services
475
Distinct HCPCS
3
Medicare payment
$47K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — below median (cohort median 2,625).
